Results 81 to 90 of about 1,185 (135)

Trade in substandard and falsified medicines

, 2022
Nhomsai Hagen, Cathrin Hauk, Lutz Heide
openaire   +1 more source

Modeling the Health and Economic Impact of Substandard and Falsified Medicines: A Review of Existing Models and Approaches. [PDF]

Am J Trop Med Hyg, 2022
Ozawa S, Higgins CR, Nwokike JI, Phanouvong S.   +3 more
europepmc   +1 more source

Quality assessment of oral antimalarial and antiretroviral medicines used by public health systems in Sahel countries.

PLoS ONE
Malaria and Human Immunodeficiency Virus infections are among the top 10 causes of death in low income countries. Furthermore, many medicines used in these treatment areas are substandard, which contributes to the high death rate.
Amor R Cáceres-Pérez, Javier Suárez-González, Ana Santoveña-Estévez, José B Fariña   +3 more
doaj   +1 more source

The silent epidemic of substandard and falsified medicines in low- and middle-income countries: heed lessons from the tragic deaths of children in Indonesia. [PDF]

Int J Surg, 2023
MohanaSundaram A, Padhi BK, Mohanty A, Shrestha S, Sah R.   +4 more
europepmc   +1 more source

Combating substandard and falsified medicines in China: policy barriers and the role of pharmaceutical track-and-trace systems

Critical Public Health
Substandard and falsified medicines (SF medicines) pose a severe threat to population health and safety. China has a large proportion of SF medicines, imposing a heavy economic burden and exacerbating inequities in access to quality medications ...
Tangsiwei Xin
doaj   +1 more source

Value for money of medicine sampling and quality testing: evidence from Indonesia

BMJ Global Health
Background Substandard and falsified medicines (SFMs) are a public health concern of global importance. Postmarket surveillance in the form of medicine sampling and quality testing can prevent and detect SFM, however, there is remarkably scarce evidence ...
Elizabeth Pisani, Adrian Gheorghe, Katharina Hauck, Amalia Hasnida, Sara Valente de Almeida, Sarah Njenga, Yunita Nugrahani, Ayu Rahmawati, Rahmi Mawaddati, Stanley Saputra, Yusi Anggriani   +10 more
doaj   +1 more source

Prevalence of Substandard and Falsified Essential Medicines [PDF]

JAMA Network Open, 2018
openaire   +2 more sources

Tackling the Burden of Substandard and Falsified Medicines and Health Technologies in Somaliland and Somalia

SSRN Electronic Journal
Background: The problem posed by the substandard and falsified (SF) medicines is a rising global challenge. WHO estimates that sales of SF medical products in low- and middle-income countries is around US$ 30 billion whereby 1 in 10 medical is substandard or falsified.
Saed Nuh Ahmed, Angela Brand
openaire   +1 more source

The spatiotemporal distribution of substandard and falsified antimalarial medicines in Africa, 1996-2019

ABSTRACT Introduction It is estimated that there were 263 million malaria cases and 597,000 deaths in 2023 globally, a substantial proportion of which are attributable to inadequate access to good-quality and efficacious antimalarials. Africa bears the highest malaria burden.
Lawrence B. Adipo, Jessica A. Mendes, Ngan Thi Do, Kerlijn Van Assche, Paula Moraga, Stella Maris Nanyonga, Nicole Stoesser, Christiane Dolecek, Paul N. Newton, Ben S. Cooper, Celine Caillet, Sean M. Cavany   +11 more
openaire   +1 more source

Motivating factors and strategies to prevent substandard and falsified medicines in low- and middle-income countries. [PDF]

J Med Access
Mwita S.
europepmc   +1 more source